Innovent Biologics (suzhou) Co. Ltd.

This study is testing an investigational drug called IBI311 for people with inactive thyroid eye disease, a condition that can cause the eyes to bulge forward. About 111 participants will be randomly assigned to receive either the drug or a placebo to see if IBI311 can safely red…

This early-stage study is testing a new drug called IBI3014 in people with advanced solid tumors that cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and see if the drug helps shrink tumors. The study will enroll about 250 adults whos…

This study is testing whether the medication IBI362 can help Chinese teenagers (ages 12-17) with obesity or overweight lose weight when diet and exercise alone haven't worked. Researchers will compare IBI362 against a placebo (inactive treatment) in 180 participants to see if it …

This study is testing whether an experimental drug called IBI362 can help people with MASH, a serious form of fatty liver disease that causes inflammation and scarring. About 165 adults with confirmed MASH will receive either a low dose, high dose, or a placebo (inactive substanc…

This is the first time a new drug called IBI343 is being tested in people. The main goals are to find a safe dose and see what side effects it causes. The study will enroll about 470 adults with advanced solid tumors that have spread or cannot be removed by surgery and have not r…

This study is testing an investigational drug called IBI356 to see if it can reduce the rash and severe itching of moderate to severe atopic dermatitis (eczema). About 403 adult participants will be randomly assigned to receive either IBI356 or a placebo to compare effectiveness …

This study is testing whether a new injectable drug called IBI3002 can safely reduce the severity of moderate to severe atopic dermatitis (eczema). About 120 adults with eczema that hasn't responded well to creams will receive either IBI3002, an approved drug (dupilumab), or a pl…

This study is testing two different drug combinations given before surgery for non-small cell lung cancer. Researchers want to see which combination works better at shrinking tumors and is safer for patients. The trial will involve 170 adults with stage IB-III lung cancer who are…

This is a first-in-human study to check the safety and how the body processes a new single-injection treatment for sudden gout attacks. It will involve 64 healthy volunteers and people experiencing an acute gout flare in China. The main goal is to see if the injection is safe and…